Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

PHASE3CompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

July 31, 2008

Study Completion Date

June 30, 2012

Conditions
Leukemia, Myelocytic, Acute
Interventions
DRUG

Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone

Since limited characters are allowed in this passage, please see detailed Description to know the dosage, dosage form, frequency of administration for the above mentioned drugs

DRUG

Etoposide, Cytarabine, Gemtuzumab, L-asparaginase, Mercaptopurine, methotrexate, Mitoxantrone, Prednisone, Vincristine

Since limited characters are allowed in this passage, please see detailed Description to know the dosage, dosage form, frequency of administration for the above mentioned drugs

Trial Locations (8)

38105

St. Jude Children's Research Hospital, Memphis

48201

Children's Hospital of Michigan (Wayne State University), Detroit

76104

Cook Children's Medical Center, Fort Worth

77030

MD Anderson Cancer Center, Houston

Texas Children's Cancer Center, Houston

94304

Stanford University Medical Center, Palo Alto

98105

Seattle Children's Hospital, Seattle

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

St. Jude Children's Research Hospital

OTHER

NCT00136084 - Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia | Biotech Hunter | Biotech Hunter